Nivolumab vs Norfloxacin
Nivolumab vs Norfloxacin: Overview
This comparison examines the pharmacological differences between Nivolumab and Norfloxacin.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Norfloxacin: Second-generation fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Norfloxacin — 3-4 hours.
Chemical Properties
Molecular Formula: Norfloxacin — C16H18FN3O3.
Molecular Weight: Norfloxacin — 319.3310 g/mol.
Type: Nivolumab — Antibody; Norfloxacin — Small molecule.